Management of asymptomatic valvular aortic stenosis

Indian Heart Journal

Volumn 54, Issue 1, 2002, Pages 31-38

  Freeman, Rosario V ^a,b   Otto, Catherine M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BENZATHINE PENICILLIN; CEFADROXIL; CEFALEXIN; CEFAZOLIN; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN ESTOLATE; ERYTHROMYCIN ETHYLSUCCINATE; PENICILLIN G; PENICILLIN V; SULFADIAZINE;

AORTA VALVE STENOSIS; DRUG EFFECT; ECHOCARDIOGRAPHY; EXERCISE TEST; HEMODYNAMICS; HUMAN; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; PREGNANCY; REVIEW; RISK ASSESSMENT; SUDDEN DEATH; TREATMENT PLANNING;

AGE FACTORS; AORTIC VALVE STENOSIS; DEATH, SUDDEN, CARDIAC; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; TREATMENT OUTCOME;

EID: 0036219984     PISSN: 00194832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly
2. Prevalence of aortic valve abnormalities in the elderly: An echocardiographic study of a random population sample
3. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study
4. Valvular, subvalvular, and supravalvular aortic stenosis: Morphologic features
5. Rapidity of progression of aortic stenosis in patients with congenital bicuspid aortic valves
6. Progression of aortic valve dysfunction in 51 adult patients with congenital bicuspid aortic valve: Assessment and follow-up by Doppler echocardiography
7. The natural history of aortic valve stenosis
8. Correlation of serum lipids, calcium, and phosphorus, diabetes mellitus and history of systemic hypertension with presence or absence of calcified or thickened aortic cusps or root in elderly patients
9. Why is there discordance between calcific aortic stenosis and coronary artery disease?
10. New insights into the progression of aortic stenosis
11. Rheumatic heart disease in the developed world: Prevalence, prevention and control
12. Changing aspects of natural history of valvular aortic stenosis
13. Patterns of progression of aortic stenosis: A longitudinal hemodynamic study
14. The natural history of aortic valve disease after mitral valve surgery
15. Aortic stenosis - Listen to the patient, look at the valve
16. Characterization of the early lesion of "degenerative" valvular aortic stenosis. Histological and immunohistochemical studies
17. Osteopontin is expressed in human aortic valvular lesions
18. Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of "degenerative" valvular aortic stenosis
19. Left ventricular systolic function in aortic stenosis
20. ACC/AHA guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease)
21. Hemodynamic determinants of prognosis of aortic valve replacement in critical aortic stenosis and advanced congestive heart failure
22. Comparison of outcome of asymptomatic to symptomatic patients older than 20 years of age with valvular aortic stenosis
23. Value of the cardiovascular examination for detecting valvular heart disease in asymptomatic subjects
24. Correlation of prevalence and severity of valvular aortic stenosis determined by continuous-wave Doppler echocardiography with physical signs of aortic stenosis in patients aged 62 to 100 years with aortic systolic ejection murmurs
25. Physical examination in valvular aortic stenosis: Correlation with stenosis severity and prediction of clinical outcome
26. Identifying severe aortic valvular stenosis by bedside examination
27. Aortic stenosis
28. The natural history of aortic stenosis in adults
29. Spontaneous course of aortic valve disease
30. Rate of progression of valvular aortic stenosis in adults
31. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome
32. Predictors of outcome in severe, asymptomatic aortic stenosis
33. The natural history of adults with asymptomatic, hemodynamically significant aortic stenosis
34. Non-invasive assessment of aortic stenosis by Doppler ultrasound
35. Progression of valvar aortic stenosis: A long-term retrospective study
36. Hemodynamic progression of aortic stenosis in adults assessed by Doppler echocardiography
37. Progression of aortic stenosis in adults: New appraisal using Doppler echocardiography
38. Progression of valvular aortic stenosis in adults: Literature review and clinical implications
39. Progression of aortic stenosis. Role of age and concomitant coronary artery disease
40. Progression of aortic stenosis in 394 patients: Relation to changes in myocardial and mitral valve dysfunction
41. Factors leading to progression of valvular aortic stenosis
42. New insights into the progression of aortic stenosis: Implications for secondary preventation
43. Rate of change in aortic valve area during a cardiac cycle can predict the rate of hemodynamic progression of aortic stenosis
44. Systemic and left ventricular responses to exercise stress of asymptomatic patients with valvular aortic stenosis
45. Exercise testing in patients with aortic stenosis
46. Physiologic changes with maximal exercise in asymptomatic valvular aortic stenosis assessed by Doppler echocardiography
47. Exercise testing to guide surgery in aortic stenosis
48. Detection of coronary artery disease by means of exercise ECG in patients with aortic stenosis
49. ACC/AHA guidelines for exercise testing. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on Exercise Testing)
50. Management of asymptomatic aortic stenosis: Masterly inactivity but cat-like observation
51. Mortality and worsening of prognostic profile during waiting time for valve replacement in aortic stenosis
52. Timing of aortic valve surgery
53. Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis
54. Percutaneous aortic balloon valvuloplasty in octogenarians: Morbidity and mortality
55. Preoperative risk evaluation and stratification of long-term survival after valve replacement for aortic stenosis. Reasons for earlier operative intervention
56. Twelve-year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses
57. A comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve or bioprosthesis. Veterans Affairs Cooperative Study on Valvular Heart Disease
58. Aortic valve replacement in the elderly: Effect of gender and coronary artery disease on operative mortality
59. Ten-year experience with aortic valve replacement in 482 patients 70 years of age or older: Operative risk and long-term results
60. To operate or not on elderly patients with aortic stenosis: The decision and its consequences
61. Long-term relative survival rates after heart valve replacement
62. Timing of surgery in aortic stenosis
63. Active and cognitive impairment-free life expectancies: Results from the Melton Mowbray 75 + health checks
64. Valvular heart disease
65. Prospective multicenter study of pregnancy outcomes in women with heart disease
66. The effect of valvular heart disease on maternal and fetal outcome of pregnancy
67. Aortic stenosis in pregnancy
68. Role of balloon dilatation of the aortic valve in pregnant patients with severe aortic stenosis
69. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: A statement for health professionals